transcription inhibitorとは 意味・読み方・使い方

A p21 expression cell is cultured for a time sufficient for producing an antiapoptosis or a mitotic factor and the cell is brought into contact with a transcription-inducing agent of an expression promotor of p21 or its transcription inhibitor is eliminated.例文帳に追加

ｐ２１発現細胞を、抗アポトーシスまたは有糸分裂因子を産生するに十分な時間培養し、ｐ２１の発現プロモーターの転写誘導剤と接触、またはその転写阻害剤を除去する。 - 特許庁

This TLR4 transcription factor activity inhibitor is characterized by containing butyric acid bacteria, butyric acid-producing bacterium metabolite, butyric acid bacterium metabolite or butyric acid.例文帳に追加

酪酸菌、酪酸産生菌の代謝物、酪酸菌の代謝物または酪酸を含むことを特徴とするＴＬＲ４転写因子活性抑制剤。 - 特許庁

TLR4 TRANSCRIPTION FACTOR ACTIVITY INHIBITOR AND ULCERATIVE COLITIS-ABATING PERIOD-INTRODUCING AGENT OR -MAINTAINING AGENT例文帳に追加

ＴＬＲ４転写因子活性抑制剤および潰瘍性大腸炎の緩解期導入剤若しくは緩解期維持剤。 - 特許庁

A nucleic acid structure includes a transcription regulatory region with its functional known or unknown, and a polyketide synthase gene expressed under the control of the transcription regulatory region, wherein the transcription regulatory region includes one promoter region selected from the group consisting of a promoter induced by an agent for improving the plant disease resistance, a promoter induced by electron transfer system inhibitor, and a promoter induced by ergosterol biosynthesis inhibitor.例文帳に追加

機能既知又は機能未知の転写制御領域と、当該転写制御領域の制御下に発現するポリケタイド合成酵素遺伝子とを含み、発現制御領域は、植物病害抵抗性付与剤誘導型プロモーター、電子伝達系阻害剤誘導型プロモーター及びエルゴステロール生合成阻害剤誘導型プロモーターからなる群から選ばれる１つのプロモーター領域を含む核酸構築物。 - 特許庁

To obtain a gene expression inhibitor through motif of transcription factor AP-1 effective for alleviation and amelioration of symptom of disease accompanied by inflammation and fever.例文帳に追加

炎症ならびに発熱を伴う疾病の症状の緩和と改善、ならびに癌増殖の抑制に有効な転写因子ＡＰ−１のモチーフを介した遺伝子発現の抑制剤を提供する。 - 特許庁

To provide an acute phase reactant transcription inhibitor originated from a safe food material, and to provide a composition for preventing and/or improving, treating diseases caused by the expression of the acute phase reactant.例文帳に追加

安全な食品素材由来である急性相反応タンパク質転写抑制剤、及び、急性相反応タンパク質の発現によって引き起こされる疾患の予防及び／又は改善・処置用組成物を提供する。 - 特許庁

The invention relates to a pharmaceutical composition for treating or restoring fibrocartilage and intervertebral disc destruction by inhibiting transcription factor NF-κB activity including administering an effective amount of a transcription factor inhibitor selected from the group consisting of an NF-κB (nuclear factorκB ) decoy, an antisense to NF-κB, a ribozyme and an siRNA.例文帳に追加

ＮＦ−κＢ（核内因子κＢ）デコイ、ＮＦ−κＢに対するアンチセンス、リボザイム及びｓｉＲＮＡからなる群から選択される転写因子阻害剤の有効量を含む、転写因子ＮＦ−κＢの活性を阻害することによる、繊維軟骨及び椎間板の破壊の治療又は修復のための医薬組成物。 - 特許庁

According to the present invention, the acute phase reactant transcription inhibitor containing a hydrophobic extract of licorice as an active ingredient is obtained, and a composition for preventing and/or improving, treating diseases related to tissue damages, etc., caused by the expression of acute phase reactant is provided.例文帳に追加

本発明により、甘草疎水性抽出物を有効成分とする急性相反応タンパク質転写抑制剤が得られ、急性相反応タンパク質によって引き起こされる組織損傷等に関連する疾患の予防及び／又は改善・処置用組成物が提供される。 - 特許庁